Global Addiction Treatment Market Research Report 2019
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Addiction Treatment Quarterly Market Size Analysis
- 2.1 Addiction Treatment Business Impact Assessment - COVID-19
- 2.1.1 Global Addiction Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Addiction Treatment Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Addiction Treatment Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Addiction Treatment Headquarters and Area Served
- 3.3 Date of Key Players Enter into Addiction Treatment Market
- 3.4 Key Players Addiction Treatment Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Addiction Treatment Segments, By Type
- 4.1 Introduction
- 1.4.1 Alcohol Addiction Treatment
- 1.4.2 Tobacco/Nicotine Addiction Treatment
- 1.4.3 Tobacco/Nicotine Addiction Treatment
- 1.4.4 Other Substance Addiction Treatment
- 4.2 By Type, Global Addiction Treatment Market Size, 2019-2021
5 Impact of Covid-19 on Addiction Treatment Segments, By Application
- 5.1 Overview
- 5.5.1 Outpatient Treatment Center
- 5.5.2 Residential Treatment Center
- 5.5.3 Inpatient Treatment Center
- 5.2 By Application, Global Addiction Treatment Market Size, 2019-2021
- 5.2.1 By Application, Global Addiction Treatment Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Cipla
- 7.1.1 Cipla Business Overview
- 7.1.2 Cipla Addiction Treatment Quarterly Revenue, 2020
- 7.1.3 Cipla Addiction Treatment Product Introduction
- 7.1.4 Cipla Response to COVID-19 and Related Developments
- 7.2 Allergan
- 7.2.1 Allergan Business Overview
- 7.2.2 Allergan Addiction Treatment Quarterly Revenue, 2020
- 7.2.3 Allergan Addiction Treatment Product Introduction
- 7.2.4 Allergan Response to COVID-19 and Related Developments
- 7.3 Alkermes
- 7.3.1 Alkermes Business Overview
- 7.3.2 Alkermes Addiction Treatment Quarterly Revenue, 2020
- 7.3.3 Alkermes Addiction Treatment Product Introduction
- 7.3.4 Alkermes Response to COVID-19 and Related Developments
- 7.4 Pfizer
- 7.4.1 Pfizer Business Overview
- 7.4.2 Pfizer Addiction Treatment Quarterly Revenue, 2020
- 7.4.3 Pfizer Addiction Treatment Product Introduction
- 7.4.4 Pfizer Response to COVID-19 and Related Developments
- 7.5 Orexo
- 7.5.1 Orexo Business Overview
- 7.5.2 Orexo Addiction Treatment Quarterly Revenue, 2020
- 7.5.3 Orexo Addiction Treatment Product Introduction
- 7.5.4 Orexo Response to COVID-19 and Related Developments
- 7.6 GlaxoSmithKiline
- 7.6.1 GlaxoSmithKiline Business Overview
- 7.6.2 GlaxoSmithKiline Addiction Treatment Quarterly Revenue, 2020
- 7.6.3 GlaxoSmithKiline Addiction Treatment Product Introduction
- 7.6.4 GlaxoSmithKiline Response to COVID-19 and Related Developments
- 7.7 Purdue Pharma
- 7.7.1 Purdue Pharma Business Overview
- 7.7.2 Purdue Pharma Addiction Treatment Quarterly Revenue, 2020
- 7.7.3 Purdue Pharma Addiction Treatment Product Introduction
- 7.7.4 Purdue Pharma Response to COVID-19 and Related Developments
- 7.8 Mallinckrodt
- 7.8.1 Mallinckrodt Business Overview
- 7.8.2 Mallinckrodt Addiction Treatment Quarterly Revenue, 2020
- 7.8.3 Mallinckrodt Addiction Treatment Product Introduction
- 7.8.4 Mallinckrodt Response to COVID-19 and Related Developments
- 7.9 Reckitt Benckiser
- 7.9.1 Reckitt Benckiser Business Overview
- 7.9.2 Reckitt Benckiser Addiction Treatment Quarterly Revenue, 2020
- 7.9.3 Reckitt Benckiser Addiction Treatment Product Introduction
- 7.9.4 Reckitt Benckiser Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
This report covers market size and forecasts of Addiction Treatment, including the following market information:
Global Addiction Treatment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Addiction Treatment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Addiction Treatment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Addiction Treatment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Cipla, Allergan, Alkermes, Pfizer, Orexo, GlaxoSmithKiline, Purdue Pharma, Mallinckrodt, Reckitt Benckiser, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Alcohol Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Other Substance Addiction Treatment
Based on the Application:
Outpatient Treatment Center
Residential Treatment Center
Inpatient Treatment Center